<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Etiology, clinical features, and evaluation of tricuspid regurgitation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Etiology, clinical features, and evaluation of tricuspid regurgitation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Etiology, clinical features, and evaluation of tricuspid regurgitation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Catherine M Otto, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            William A Zoghbi, MD, FASE, FAHA, MACC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Susan B Yeon, MD, JD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 22, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tricuspid regurgitation (TR) is a relatively common abnormality. Since this lesion is frequently asymptomatic and may not be detected on physical examination, it is often diagnosed solely by echocardiography. This topic will review the etiology, pathophysiology, and clinical features associated with regurgitation of the tricuspid valve [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Management and prognosis of TR and Ebstein anomaly of the tricuspid valve are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8145.html" rel="external">
          "Management and prognosis of tricuspid regurgitation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8146.html" rel="external">
          "Ebstein anomaly: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         A small degree of TR (trace) is present in approximately 80 percent of healthy adults [
         <a href="#rid2">
          2
         </a>
         ]. On echocardiography, this "normal" or physiological degree of regurgitation is localized to a small region adjacent to valve closure, often does not extend throughout systole, and has a low signal strength [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Abnormal degrees of TR in adults are largely secondary (ie, related to tricuspid annular dilation and/or leaflet tethering in the setting of right ventricular [RV] pressure and/or volume overload) and much less often due to primary disorders of the valve apparatus [
         <a href="#rid4">
          4-7
         </a>
         ]. The frequency of TR as well as valvular pathology was evaluated in a study of 5223 adults (predominantly male with a mean age of 67) who underwent echocardiography at three Veterans Affairs medical centers [
         <a href="#rid4">
          4
         </a>
         ]. Moderate to severe TR was present in 819 (15.7 percent), but only 8 percent had primary tricuspid valve pathology.
        </p>
        <p>
         Implantable device leads that cross the tricuspid valve may cause acute or chronic TR. The reported frequency of pacemaker lead-associated TR ranges from 7 to 45 percent, can be progressive, and is associated with an increased rate of adverse clinical outcomes [
         <a href="#rid8">
          8-10
         </a>
         ]. The causes of pacer-associated TR include: effects of chronic RV pacing on RV geometry and systolic function, direct impingement on leaflet motion, foreign body inflammation and fibrosis of the leaflets, thrombosis, and endocarditis [
         <a href="#rid11">
          11-14
         </a>
         ]. In a retrospective series of 239 patients undergoing first device implantation with either a pacer or cardioverter-defibrillator lead crossing the tricuspid valve, 38 percent developed significant lead-associated TR within 1 to 1.5 years [
         <a href="#rid8">
          8,15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Secondary TR
         </span>
         <span class="headingEndMark">
          —
         </span>
         TR in adults is most commonly secondary (or functional), defined as regurgitation with apparently anatomically normal leaflets and chords.
        </p>
        <p>
         The cause of secondary TR most likely is dilation of the right atrium and RV with dilation of the tricuspid annulus [
         <a href="#rid16">
          16
         </a>
         ] and tethering of the tricuspid valve leaflets, although the mechanism of valve dysfunction has not been fully defined [
         <a href="#rid6">
          6,17
         </a>
         ]. RV dilation, tricuspid annular dilation, and tricuspid leaflet tethering may result from any condition that directly involves the RV or causes elevation in RV systolic pressure often with pulmonary hypertension.
        </p>
        <p>
         The association between TR and pulmonary hypertension was illustrated by an echocardiographic study of 242 patients with severe TR. TR was secondary in 219 patients (90 percent), most often (157/219 or 72 percent) in association with documented significant pulmonary hypertension (defined as pulmonary artery pressure &gt;50 mmHg; causes unspecified) [
         <a href="#rid5">
          5
         </a>
         ]. There were 58 patients (26 percent) with severe secondary TR who did not have documented significant pulmonary hypertension. However, approximately half of these patients had factors suggestive of undocumented pulmonary hypertension or occult tricuspid disease including primary mitral disease, severe left ventricular dysfunction, and/or severe secondary mitral regurgitation. In the 23 patients (2 percent) with severe secondary TR and no evidence of pulmonary hypertension, six had tricuspid valve malcoaptation and two had indeterminate coaptation. In the 15 patients with no evident cause of severe TR, 14 had a history of atrial fibrillation (AF; 7 percent of the total secondary TR group).
        </p>
        <p>
         The disorders that induce pulmonary hypertension and secondary RV dilatation include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Left-sided heart failure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mitral stenosis or regurgitation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Primary pulmonary disease – Cor pulmonale, pulmonary embolism, pulmonary hypertension of any cause
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Left to right shunt – Atrial septal defect, ventricular septal defect, anomalous pulmonary venous return
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eisenmenger syndrome
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stenosis of the pulmonic valve or pulmonary artery
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hyperthyroidism (see
         <a class="medical medical_review" href="/z/d/html/7853.html" rel="external">
          "Cardiovascular effects of hyperthyroidism"
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         In other studies, severe secondary TR has been attributed to and/or associated with AF [
         <a href="#rid18">
          18-20
         </a>
         ]. In a series of 87 patients with TR severe enough for consideration of intervention, mean age was 80 (56 percent female), nearly all were in AF (93 percent), and chronic kidney disease was common (64 percent) [
         <a href="#rid21">
          21
         </a>
         ]. There was at least moderate RV dysfunction in 47 percent. Most of these patients (75 percent) did not undergo intervention. Overall, 30-day and one-year survival rates were 100 and 76 percent, respectively.
        </p>
        <p>
         Patients undergoing surgery for severe TR do not reflect the larger population of patients in whom surgical intervention is not indicated or considered, as illustrated by the following study. In a series of 466 patients undergoing surgery for isolated severe TR, mean age was 60 years, 49 percent were female, 41 percent had hypertension, 40 percent were in atrial fibrillation, and 33 percent had renal insufficiency [
         <a href="#rid22">
          22
         </a>
         ]. TR was secondary in 49 percent, with approximately one-half having previous left-sided valve surgery and one-half having annular dilation in the absence of left-sided valve disease.
        </p>
        <p>
         Examples of RV diseases causing secondary TR include cardiomyopathies affecting one or both ventricles and ischemic heart disease, which may involve the RV myocardial and tricuspid papillary muscles [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
         Factors predictive of TR severity were evaluated in an echocardiographic review of 2139 patients without primary tricuspid valve disease [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe TR was associated with higher pulmonary artery systolic pressure (PASP), AF, right atrial and RV enlargement, left ventricular dysfunction, and primary mitral valve disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Moderate or severe TR was associated with most of these factors, as well as presence of an RV pacemaker lead, older age, and female sex.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Although TR severity was associated with higher PASP, many patients with pulmonary hypertension had only mild TR (65 percent of patients with PASP 50 to 69 mmHg and 46 percent with PASP ≥70 mmHg).
        </p>
        <p>
        </p>
        <p>
         Severe secondary TR is also associated with AF, but whether the effects of TR such as right atrial enlargement increase the likelihood of AF or whether chronic AF increases the likelihood of TR is not known [
         <a href="#rid19">
          19,20
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Primary TR
         </span>
         <span class="headingEndMark">
          —
         </span>
         TR in adults is less often due to processes that directly affect the tricuspid valve (primary or "organic" valve disease); for example, primary tricuspid valve disease was found in only 23 patients (10 percent) of 242 patients with severe TR [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Causes of primary TR include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Endovascular pacemaker defibrillator leads crossing a native or bioprosthetic tricuspid valve can cause or exacerbate TR by impingement on a valve leaflet, leaflet tethering to the lead, leaflet perforation, or entanglement of the lead with subvalvular chordae [
         <a href="#rid9">
          9
         </a>
         ]. Transvalvular pacemaker leads also increase the risk of recurrent regurgitation after tricuspid valve repair [
         <a href="#rid24">
          24
         </a>
         ]. Endomyocardial biopsy is another cause of tricuspid valve apparatus injury. (See
         <a class="medical medical_review" href="/z/d/html/989.html" rel="external">
          "Cardiac implantable electronic devices: Long-term complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3519.html" rel="external">
          "Heart transplantation in adults: Diagnosis of allograft rejection", section on 'Endomyocardial biopsy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, in some patients with pacemakers, the TR is secondary to RV pacing (possibly related to RV dyssynchrony), rather than the pacer lead [
         <a href="#rid12">
          12,25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Chest wall or deceleration injury trauma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infective endocarditis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ebstein anomaly, the most common form of congenital disease affecting the tricuspid valve. (See
         <a class="medical medical_review" href="/z/d/html/8146.html" rel="external">
          "Ebstein anomaly: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rheumatic valve disease. (See
         <a class="medical medical_review" href="/z/d/html/13612.html" rel="external">
          "Clinical manifestations and diagnosis of rheumatic heart disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Carcinoid syndrome. (See
         <a class="medical medical_review" href="/z/d/html/8135.html" rel="external">
          "Carcinoid heart disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ischemic heart disease affecting the RV with papillary muscle dysfunction or rupture.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Myxomatous degeneration associated with tricuspid valve prolapse, which occurs in as many as 40 percent of patients with prolapse of the mitral valve.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Connective tissue disorder (eg, Marfan syndrome). (See
         <a class="medical medical_review" href="/z/d/html/8150.html" rel="external">
          "Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Marantic endocarditis in systemic lupus erythematosus or rheumatoid arthritis. (See
         <a class="medical medical_review" href="/z/d/html/4680.html" rel="external">
          "Non-coronary cardiac manifestations of systemic lupus erythematosus in adults", section on 'Valvular disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Drug-induced disease. There was an association between TR and the combined use of the anorectic drugs,
         <a class="drug drug_general" data-topicid="128557" href="/z/d/drug information/128557.html" rel="external">
          fenfluramine
         </a>
         and
         <a class="drug drug_general" data-topicid="9765" href="/z/d/drug information/9765.html" rel="external">
          phentermine
         </a>
         , in some studies. The dopamine agonist pergolide may induce TR by a mechanism similar to that with anorectic drugs and carcinoid syndrome [
         <a href="#rid26">
          26,27
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8125.html" rel="external">
          "Valvular heart disease induced by drugs"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The cause of primary TR in adolescents and young adults [
         <a href="#rid7">
          7
         </a>
         ] usually is congenital, with Ebstein anomaly being most common. Acquired TR is rare in adolescents and young adults except for occasional cases due to trauma, infective endocarditis in intravenous drug users, and valve injury due to the jet through a small ventricular septal defect. (See
         <a class="medical medical_review" href="/z/d/html/8146.html" rel="external">
          "Ebstein anomaly: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2149.html" rel="external">
          "Right-sided native valve infective endocarditis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          PATHOPHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         TR is characterized by the backflow of blood into the right atrium during systole. Since the right atrium is relatively compliant, there are often no major hemodynamic consequences with mild or moderately severe TR. However, when TR is severe, right atrial and venous pressures rise and can result in the signs and symptoms of right-sided heart failure  (
         <a class="graphic graphic_figure graphicRef142481" href="/z/d/graphic/142481.html" rel="external">
          figure 1
         </a>
         ), including ascites and liver failure. In such patients, chronic RV pressure and/or volume overload frequently lead to RV systolic dysfunction and a low forward cardiac output [
         <a href="#rid28">
          28
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8127.html" rel="external">
          "Hemodynamics of valvular disorders as measured by cardiac catheterization"
         </a>
         .)
        </p>
        <p>
         Elevated central venous pressure in patients with severe TR may contribute to impaired renal function regardless of the etiology of the regurgitant lesion [
         <a href="#rid29">
          29,30
         </a>
         ]. Studies have shown that increasing intra-abdominal or central venous pressure, which should also increase renal venous pressure, reduced glomerular filtration rate. Such an effect is not closely related to the cardiac output. (See
         <a class="medical medical_review" href="/z/d/html/13606.html" rel="external">
          "Cardiorenal syndrome: Definition, prevalence, diagnosis, and pathophysiology", section on 'Increased renal venous pressure'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3569351977">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are often no specific symptoms associated with mild or moderate TR alone. With severe disease, there may be a sensation of pulsation in the neck (from the distended and pulsatile jugular veins) and symptoms of right-sided heart failure (HF) such as painful hepatosplenomegaly, ascites, and peripheral edema. Some patients with severe TR remain asymptomatic for many years. It remains unclear why some patients tolerate this lesion and others do not.
        </p>
        <p>
         Symptoms may also arise from the underlying cause of regurgitation. As an example, pulmonary hypertension (whether primary or secondary) may lead to symptoms of low cardiac output, including fatigue, weakness, shortness of breath, and exercise intolerance. Patients with carcinoid valve disease often present with symptoms of carcinoid syndrome with cardiac involvement only diagnosed after imaging studies. (See
         <a class="medical medical_review" href="/z/d/html/8249.html" rel="external">
          "Clinical features and diagnosis of pulmonary hypertension of unclear etiology in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2614.html" rel="external">
          "Clinical features of carcinoid syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most prominent features of the physical examination in patients with TR are those related to the regurgitant murmur and the development of right-sided HF. With severe right HF, the patient often looks cachectic, chronically ill, cyanotic, and occasionally jaundiced (reflecting hepatic dysfunction). If TR is due to left ventricular dysfunction, signs of left-sided HF may dominate.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Jugular veins
         </span>
         <span class="headingEndMark">
          —
         </span>
         Distended and prominent jugular veins are apparent and reflect the elevation in right atrial pressure  (
         <a class="graphic graphic_figure graphicRef71775" href="/z/d/graphic/71775.html" rel="external">
          figure 2
         </a>
         and
         <a class="graphic graphic_waveform graphicRef51876" href="/z/d/graphic/51876.html" rel="external">
          waveform 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/1076.html" rel="external">
          "Examination of the jugular venous pulse"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is a distinct "c-v" (regurgitant) wave due to systolic regurgitation into the right atrium.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The jugular vein is very pulsatile and may be confused with the carotid arterial pulse. (See
         <a class="medical medical_review" href="/z/d/html/1076.html" rel="external">
          "Examination of the jugular venous pulse"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Jugular venous distension may be more prominent with inspiration (Kussmaul sign), a result of the increase in venous return. This finding, however, may not be very obvious with marked venous distension.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A systolic thrill may be felt over the jugular vein in patients with severe regurgitation.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Palpation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Palpation of the chest may reveal a dynamic RV heave due to the dilated RV. A dilated pulmonary artery may also be suggested by dullness and a prominent pulsation over the left second intercostal space, a finding most often observed with pulmonary hypertension. When the TR is very severe, a pulsation may be detected along the right sternal border due to flow into the right atrium.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h3">
          Edema
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ascites and peripheral edema of variable severity may be present, and anasarca can occur in severe disease. There is frequent evidence of unilateral or bilateral pleural effusions, which are more common when the TR results from pulmonary hypertension secondary to a left-sided cardiac problem (valvular or myocardial).
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Hepatomegaly
         </span>
         <span class="headingEndMark">
          —
         </span>
         The liver is often enlarged and tender, and may be pulsatile in severe TR. Occasionally, the systolic murmur may be transmitted to and heard over the liver (with a thrill).
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Cardiac auscultation
         </span>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h4">
          Murmur
         </span>
         <span class="headingEndMark">
          —
         </span>
         TR is classically associated with a holosystolic murmur that is best heard at the right or left mid sternal border or at the subxiphoid area. When the RV is very enlarged, the murmur may even be appreciated at the apex. There is usually little radiation of the murmur, and a thrill is generally not palpable. However, the murmur of TR is often soft or absent, even when regurgitation is severe. (See
         <a class="medical medical_review" href="/z/d/html/1078.html" rel="external">
          "Auscultation of cardiac murmurs in adults"
         </a>
         .)
        </p>
        <p>
         Diastolic murmurs are usually absent in TR, although a diastolic rumble may be heard particularly if there is associated tricuspid stenosis or when there is substantial blood flow across the tricuspid valve during diastole, which may occur with an atrial septal defect.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h4">
          Maneuvers
         </span>
         <span class="headingEndMark">
          —
         </span>
         Interventions that result in an increase in venous return (leg raising, exercise, hepatic compression) will augment the murmur of TR. The murmur may also become louder after a premature beat and prolonged diastole. On the other hand, reducing venous return (with standing) will diminish the intensity of the murmur. In patients with pulmonary hypertension, the intensity of the murmur may change with changes in pulmonary artery pressure. (See
         <a class="medical medical_review" href="/z/d/html/1080.html" rel="external">
          "Physiologic and pharmacologic maneuvers in the differential diagnosis of heart murmurs and sounds"
         </a>
         .)
        </p>
        <p>
         Respiratory variation in the intensity and duration of the murmur (Rivero-Carvallo's sign) may be observed with mild to moderate TR. With inspiration, there is an increase in venous return to the RV; as a result, the murmur of TR becomes louder and may become longer (unless it is already holosystolic).
        </p>
        <p>
         The respiratory variation may occasionally be augmented when the patient is standing and venous return is reduced. On the other hand, respiratory variation may not be appreciated in patients with severe TR or marked RV enlargement and dysfunction.
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h4">
          Heart sounds
         </span>
         <span class="headingEndMark">
          —
         </span>
         An S3, which may vary in intensity and with inspiration, is often associated with an extremely dilated RV. An S4 may also be heard if there is significant RV hypertrophy. The intensity of P2 may be increased and splitting of S2 may be marked in patients with pulmonary hypertension. (See
         <a class="medical medical_review" href="/z/d/html/1079.html" rel="external">
          "Auscultation of heart sounds"
         </a>
         .)
        </p>
        <p>
         When there are other associated cardiac abnormalities, auscultatory findings of these conditions also may be appreciated.
        </p>
        <p class="headingAnchor" id="H1531762465">
         <span class="h2">
          Initial tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Electrocardiography and chest radiography are not required to diagnose TR but are commonly obtained in evaluating patients with TR. Electrocardiography and chest radiography may reveal findings reflective of right atrial and RV enlargement and concomitant left heart disease, if present.
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h3">
          Electrocardiogram
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are no electrocardiographic (ECG) changes characteristic of mild TR except for nonspecific ST and T wave abnormalities in the right precordial leads that reflect RV dysfunction. If the cause is RV infarction, there is often ECG evidence of an inferior or posterior wall myocardial infarction. In this setting, right-sided precordial leads may demonstrate Q waves, particularly in leads V3R to V5R  (
         <a class="graphic graphic_waveform graphicRef82739" href="/z/d/graphic/82739.html" rel="external">
          waveform 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/75.html" rel="external">
          "Right ventricular myocardial infarction"
         </a>
         .)
        </p>
        <p>
         When the cause for TR is pulmonary hypertension, the ECG may show evidence for RV hypertrophy with right axis deviation and tall R waves in V1 to V2 (R&gt;S or R/S&gt;1)  (
         <a class="graphic graphic_waveform graphicRef67622" href="/z/d/graphic/67622.html" rel="external">
          waveform 3
         </a>
         ). Incomplete (or rarely complete) right bundle branch block is occasionally present.
        </p>
        <p>
         With severe pulmonary hypertension, right atrial hypertrophy and "P-pulmonale" may also be present. With P-pulmonale, the P wave is tall in amplitude, narrow in duration, and peaked; these changes are especially prominent in leads II, III, aVF, and V1  (
         <a class="graphic graphic_waveform graphicRef64928" href="/z/d/graphic/64928.html" rel="external">
          waveform 4
         </a>
         ). In addition, the terminal negative component of the P wave is absent in lead V1 (see
         <a class="medical medical_review" href="/z/d/html/8249.html" rel="external">
          "Clinical features and diagnosis of pulmonary hypertension of unclear etiology in adults"
         </a>
         ). If atrial fibrillation is present, the fibrillatory waves may be coarse and of increased amplitude (reflecting right atrial hypertrophy).
        </p>
        <p>
         Changes of underlying left heart disease may be present when the cause of the TR is pulmonary hypertension secondary to an associated left-sided cardiac abnormality.
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Chest radiograph
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chest radiographs of patients with severe TR reveal cardiomegaly due to RV enlargement. A prominent cardiac silhouette is observed on the right with the posteroanterior (PA) view, and the enlarged RV fills in the retrosternal space on the lateral film  (
         <a class="graphic graphic_diagnosticimage graphicRef72063" href="/z/d/graphic/72063.html" rel="external">
          image 1
         </a>
         ). Additional findings may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evidence of right atrial enlargement
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An azygos vein may be seen when the pressure is increased
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pleural effusions and upward displacement of the diaphragm due to ascites may occasionally be observed
        </p>
        <p>
        </p>
        <p>
         When the cause of the TR is pulmonary hypertension secondary to a left-sided cardiac abnormality, other radiographic findings may be seen, particularly prominent right and left pulmonary artery hilar segments.
        </p>
        <p class="headingAnchor" id="H164375718">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Echocardiography is the main diagnostic modality for identification of TR and evaluation of its severity and cause [
         <a href="#rid31">
          31
         </a>
         ]. Most cases of TR in adults are secondary, although there are a variety of acquired diseases involving the tricuspid valve. By contrast, most cases of TR due to valve disease in adolescents and young adults are congenital, with Ebstein anomaly being most common [
         <a href="#rid7">
          7
         </a>
         ]. Evaluation of Ebstein anomaly is discussed separately. (See
         <a class="local">
          'Etiology'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/8146.html" rel="external">
          "Ebstein anomaly: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         Cardiovascular magnetic resonance (CMR) may be helpful if further quantitative evaluation of RV size and systolic function is indicated. (See
         <a class="local">
          'Cardiovascular magnetic resonance'
         </a>
         below.)
        </p>
        <p>
         Cardiac catheterization is generally not required but may be helpful to evaluate pulmonary artery hypertension, with direct pressure measurements and evaluation of pulmonary vascular resistance. (See
         <a class="local">
          'Cardiac catheterization and angiography'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Echocardiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Echocardiography is the main diagnostic tool for identification and evaluation of TR  (
         <a class="graphic graphic_movie graphicRef68814" href="/z/d/graphic/68814.html" rel="external">
          movie 1
         </a>
         ). Echocardiographic evaluation of the tricuspid valve is discussed in detail elsewhere, but the major findings will be summarized here  (
         <a class="graphic graphic_table graphicRef131166" href="/z/d/graphic/131166.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5292.html" rel="external">
          "Echocardiographic evaluation of the tricuspid valve", section on 'Tricuspid regurgitation'
         </a>
         .)
        </p>
        <p>
         Echocardiographic findings include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tricuspid valve leaflets and motion may be normal or abnormal. Characteristic primary valvular abnormalities include Ebstein anomaly, carcinoid heart disease, rheumatic valve disease, leaflet prolapse, flail leaflet, and endocarditis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Echocardiography, particularly three-dimensional transesophageal echocardiography (3D TEE), is helpful for identifying and defining the mechanism of pacer-lead-related TR [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The RV, tricuspid annulus, and right atrium are usually dilated in the presence of moderate to severe TR (unless the TR is acute)  (
         <a class="graphic graphic_figure graphicRef142481" href="/z/d/graphic/142481.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_movie graphicRef68814" href="/z/d/graphic/68814.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_movie graphicRef53665" href="/z/d/graphic/53665.html" rel="external">
          movie 2
         </a>
         and
         <a class="graphic graphic_movie graphicRef68261" href="/z/d/graphic/68261.html" rel="external">
          movie 3
         </a>
         and
         <a class="graphic graphic_movie graphicRef56009" href="/z/d/graphic/56009.html" rel="external">
          movie 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severity of TR is determined by integration of several imaging and Doppler findings  (
         <a class="graphic graphic_movie graphicRef68814" href="/z/d/graphic/68814.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_movie graphicRef56009" href="/z/d/graphic/56009.html" rel="external">
          movie 4
         </a>
         and
         <a class="graphic graphic_movie graphicRef70050" href="/z/d/graphic/70050.html" rel="external">
          movie 5
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The major Doppler criteria for severe TR are a vena contracta width of 0.7 cm or greater and systolic flow reversal in the hepatic veins [
         <a href="#rid3">
          3,7
         </a>
         ]. However, hepatic vein systolic flow reversal is not accurate unless sinus rhythm is present, because normal atrial filling during ventricular systole depends on a preceding normal atrial contraction  (
         <a class="graphic graphic_movie graphicRef50740" href="/z/d/graphic/50740.html" rel="external">
          movie 6
         </a>
         and
         <a class="graphic graphic_movie graphicRef60413" href="/z/d/graphic/60413.html" rel="external">
          movie 7
         </a>
         ) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         3D imaging with 3D Doppler may be helpful in some cases [
         <a href="#rid32">
          32,33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Interventricular septal movement may be paradoxical, reflecting the increased volume within the RV (diastolic overload) or due to pulmonary hypertension in patients with secondary TR.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         RV function may be hyperdynamic, normal, or reduced, reflecting the underlying cause of TR and the degree of RV compensation. Normal RV systolic function is defined by several parameters, including tricuspid annular plane systolic excursion &gt;16 mm, tricuspid valve systolic annular velocity &gt;10.0 cm/s, and RV end-systolic area &lt;20.0 cm
         <sup>
          2
         </sup>
         or fractional area change &gt;35 percent. Other imaging modalities, such as 3D TEE, cardiovascular magnetic resonance imaging, and computed tomography, may provide more accurate information on the status of the RV. (See
         <a class="medical medical_review" href="/z/d/html/120068.html" rel="external">
          "Approach to evaluation of the right ventricle in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83974.html" rel="external">
          "Echocardiographic assessment of the right heart"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The degree of pulmonary hypertension often can be accurately measured by estimating the RV to right atrial systolic gradient from the velocity of the TR jet (using the modified Bernoulli equation) and adding this gradient to an estimate of right atrial pressure. However, estimation of right atrial pressure may be inaccurate when TR is severe, leading to underestimation of pulmonary systolic pressure [
         <a href="#rid34">
          34,35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5292.html" rel="external">
          "Echocardiographic evaluation of the tricuspid valve", section on 'Continuous wave Doppler'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If Doppler echocardiographic data are inadequate or discordant, invasive measurement of pulmonary artery pressures and calculation of pulmonary vascular resistance may be helpful [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Evaluation of the left heart may identify a cause for pulmonary hypertension and secondary TR, such as mitral stenosis, mitral regurgitation, LV systolic or diastolic dysfunction, or aortic valve disease. (See
         <a class="medical medical_review" href="/z/d/html/112486.html" rel="external">
          "Pulmonary hypertension due to left heart disease (group 2 pulmonary hypertension) in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Cardiovascular magnetic resonance
         </span>
         <span class="headingEndMark">
          —
         </span>
         CMR imaging may be helpful if echocardiographic evaluation is suboptimal or inconclusive for assessment of TR severity and RV size and function [
         <a href="#rid3">
          3,37,38
         </a>
         ]. CMR enables quantitative assessment of tricuspid regurgitant volume, regurgitant fraction (the ratio of TR volume to stroke volume), RV volumes and ejection fraction, as well as evaluation of associated LV and mitral disease [
         <a href="#rid39">
          39
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5314.html" rel="external">
          "Clinical utility of cardiovascular magnetic resonance imaging"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          Cardiac catheterization and angiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cardiac catheterization and contrast right ventriculography are not helpful for the diagnosis or evaluation of TR in most patients. However, right heart catheterization of measurement of pulmonary pressures and pulmonary vascular resistance is appropriate in patients with TR when clinical and noninvasive data regarding pulmonary pressures are discordant. Left heart catheterization may be helpful to assess potential causes of secondary TR (eg, left-sided valve or myocardial disease with an elevated left atrial pressure). (See
         <a class="medical medical_review" href="/z/d/html/8127.html" rel="external">
          "Hemodynamics of valvular disorders as measured by cardiac catheterization"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H243083070">
         <span class="h2">
          Stages of tricuspid regurgitation
         </span>
         <span class="headingEndMark">
          —
         </span>
         TR is staged as mild to moderate (or progressive, stage B), asymptomatic severe (Stage C), or symptomatic severe TR (Stage D)  (
         <a class="graphic graphic_table graphicRef131166" href="/z/d/graphic/131166.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H928007780">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115482.html" rel="external">
          "Society guideline links: Cardiac valve disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12913304">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/83896.html" rel="external">
          "Patient education: Tricuspid regurgitation (The Basics)"
         </a>
         )
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tricuspid regurgitation (TR) in adults is most commonly secondary, caused by dilatation of the right atrium and right ventricle (RV) with dilation of the tricuspid annulus and tethering of the tricuspid valve leaflets. It is much less commonly caused by primary valve disease. (See
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Causes of primary acquired tricuspid valve disease leading to TR include valve injury from a permanent pacemaker or implantable cardioverter-defibrillator lead, chest trauma, endocarditis, rheumatic fever, carcinoid syndrome, ischemic disease affecting the RV, and myxomatous degeneration associated with tricuspid valve prolapse. Ebstein anomaly is the most common congenital cause of TR. (See
         <a class="local">
          'Etiology'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/8146.html" rel="external">
          "Ebstein anomaly: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptoms of severe TR are variable. They may include a sensation of pulsation in the neck and symptoms of right-sided heart failure such as painful hepatosplenomegaly and edema. However, some patients with severe TR remain asymptomatic for many years. (See
         <a class="local">
          'Symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physical findings that may be seen with severe TR include jugular venous distention, RV heave, peripheral edema, ascites, and hepatomegaly. A holosystolic murmur of TR may be heard but this may be soft or absent even when the TR is severe. (See
         <a class="local">
          'Physical examination'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Electrocardiography and chest radiography may reveal findings reflective of right atrial and RV enlargement and concomitant left heart disease, if present. (See
         <a class="local">
          'Initial tests'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Echocardiography is the main diagnostic modality for evaluation of TR. It enables evaluation of the severity of TR, valve morphology, right chamber sizes and RV function, estimation of pulmonary artery systolic pressure, as well as assessment of any concomitant left heart disease. Cardiovascular magnetic resonance imaging may be helpful if echocardiographic evaluation is suboptimal or inconclusive for assessment of TR severity and RV size and function.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Fender EA, Zack CJ, Nishimura RA. Isolated tricuspid regurgitation: outcomes and therapeutic interventions. Heart 2018; 104:798.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999; 83:897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 2017; 30:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mutlak D, Lessick J, Reisner SA, et al. Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr 2007; 20:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tornos Mas P, Rodríguez-Palomares JF, Antunes MJ. Secondary tricuspid valve regurgitation: a forgotten entity. Heart 2015; 101:1840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143:e72.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Höke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart 2014; 100:960.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Addetia K, Harb SC, Hahn RT, et al. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation. JACC Cardiovasc Imaging 2019; 12:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riesenhuber M, Spannbauer A, Gwechenberger M, et al. Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation. Clin Res Cardiol 2021; 110:884.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Bawardy R, Krishnaswamy A, Bhargava M, et al. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review. Clin Cardiol 2013; 36:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaturi M, Kusniec J, Shapira Y, et al. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr 2010; 11:550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang JD, Manning WJ, Ebrille E, Zimetbaum PJ. Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation. J Am Coll Cardiol 2017; 69:2331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delling FN, Hassan ZK, Piatkowski G, et al. Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads. Am J Cardiol 2016; 117:988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin G, Brady PA. Device lead-induced tricuspid regurgitation: does it matter? Heart 2014; 100:900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sagie A, Schwammenthal E, Padial LR, et al. Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients. J Am Coll Cardiol 1994; 24:446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spinner EM, Lerakis S, Higginson J, et al. Correlates of tricuspid regurgitation as determined by 3D echocardiography: pulmonary arterial pressure, ventricle geometry, annular dilatation, and papillary muscle displacement. Circ Cardiovasc Imaging 2012; 5:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part III. Clin Cardiol 1995; 18:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamasaki N, Kondo F, Kubo T, et al. Severe tricuspid regurgitation in the aged: atrial remodeling associated with long-standing atrial fibrillation. J Cardiol 2006; 48:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mutlak D, Aronson D, Lessick J, et al. Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity? Chest 2009; 135:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ingraham BS, Pislaru SV, Nkomo VT, et al. Characteristics and treatment strategies for severe tricuspid regurgitation. Heart 2019; 105:1244.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dreyfus J, Audureau E, Bohbot Y, et al. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J 2022; 43:654.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Navia JL, Elgharably H, Javadikasgari H, et al. Tricuspid Regurgitation Associated With Ischemic Mitral Regurgitation: Characterization, Evolution After Mitral Surgery, and Value of Tricuspid Repair. Ann Thorac Surg 2017; 104:501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazine A, Bouchard D, Moss E, et al. Transvalvular pacemaker leads increase the recurrence of regurgitation after tricuspid valve repair. Ann Thorac Surg 2013; 96:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delgado V, Tops LF, Trines SA, et al. Acute effects of right ventricular apical pacing on left ventricular synchrony and mechanics. Circ Arrhythm Electrophysiol 2009; 2:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pritchett AM, Morrison JF, Edwards WD, et al. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 2002; 77:1280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baseman DG, O'Suilleabhain PE, Reimold SC, et al. Pergolide use in Parkinson disease is associated with cardiac valve regurgitation. Neurology 2004; 63:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hahn RT, Waxman AB, Denti P, Delhaas T. Anatomic Relationship of the Complex Tricuspid Valve, Right Ventricle, and Pulmonary Vasculature: A Review. JAMA Cardiol 2019; 4:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maeder MT, Holst DP, Kaye DM. Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure. J Card Fail 2008; 14:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mullens W, Abrahams Z, Francis GS, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 2009; 53:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hahn RT. State-of-the-Art Review of Echocardiographic Imaging in the Evaluation and Treatment of Functional Tricuspid Regurgitation. Circ Cardiovasc Imaging 2016; 9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Utsunomiya H, Harada Y, Susawa H, et al. Comprehensive Evaluation of Tricuspid Regurgitation Location and Severity Using Vena Contracta Analysis: A Color Doppler Three-Dimensional Transesophageal Echocardiographic Study. J Am Soc Echocardiogr 2019; 32:1526.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hahn RT, Thomas JD, Khalique OK, et al. Imaging Assessment of Tricuspid Regurgitation Severity. JACC Cardiovasc Imaging 2019; 12:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Omori T, Kuwajima K, Rader F, et al. Implication of Right Atrial Pressure Estimated by Echocardiography in Patients with Severe Tricuspid Regurgitation. J Am Soc Echocardiogr 2023; 36:1170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stolz L, Weckbach LT, Karam N, et al. Invasive Right Ventricular to Pulmonary Artery Coupling in Patients Undergoing Transcatheter Edge-to-Edge Tricuspid Valve Repair. JACC Cardiovasc Imaging 2023; 16:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hahn RT. Finding concordance in discord: the value of discordant invasive and echocardiographic pulmonary artery pressure measurements with severe tricuspid regurgitation. Eur Heart J 2020; 41:2796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Driessen MMP, Schings MA, Sieswerda GT, et al. Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography. J Cardiovasc Magn Reson 2018; 20:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddy ST, Shah M, Doyle M, et al. Evaluation of cardiac valvular regurgitant lesions by cardiac MRI sequences: comparison of a four-valve semi-quantitative versus quantitative approach. J Heart Valve Dis 2013; 22:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lancellotti P, Pibarot P, Chambers J, et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging 2022; 23:e171.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 8119 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29229649" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Isolated tricuspid regurgitation: outcomes and therapeutic interventions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10190406" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28314623" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15013122" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Impact of tricuspid regurgitation on long-term survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17400120" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26503944" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Secondary tricuspid valve regurgitation: a forgotten entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33332150" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24449717" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30947905" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33566185" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23529935" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20185527" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28473139" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26833208" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24670417" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Device lead-induced tricuspid regurgitation: does it matter?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8034882" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22109981" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Correlates of tricuspid regurgitation as determined by 3D echocardiography: pulmonary arterial pressure, ventricle geometry, annular dilatation, and papillary muscle displacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7788951" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part III.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17243626" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Severe tricuspid regurgitation in the aged: atrial remodeling associated with long-standing atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18719061" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Functional tricuspid regurgitation in patients with pulmonary hypertension: is pulmonary artery pressure the only determinant of regurgitation severity?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31092546" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Characteristics and treatment strategies for severe tricuspid regurgitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34586392" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28223050" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Tricuspid Regurgitation Associated With Ischemic Mitral Regurgitation: Characterization, Evolution After Mitral Surgery, and Value of Tricuspid Repair.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23866803" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Transvalvular pacemaker leads increase the recurrence of regurgitation after tricuspid valve repair.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19808458" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Acute effects of right ventricular apical pacing on left ventricular synchrony and mechanics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12479512" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Valvular heart disease in patients taking pergolide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15277624" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Pergolide use in Parkinson disease is associated with cardiac valve regurgitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30994879" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Anatomic Relationship of the Complex Tricuspid Valve, Right Ventricle, and Pulmonary Vasculature: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19041045" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Tricuspid regurgitation contributes to renal dysfunction in patients with heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19215833" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27974407" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : State-of-the-Art Review of Echocardiographic Imaging in the Evaluation and Treatment of Functional Tricuspid Regurgitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31563434" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Comprehensive Evaluation of Tricuspid Regurgitation Location and Severity Using Vena Contracta Analysis: A Color Doppler Three-Dimensional Transesophageal Echocardiographic Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30846122" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Imaging Assessment of Tricuspid Regurgitation Severity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37356676" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Implication of Right Atrial Pressure Estimated by Echocardiography in Patients with Severe Tricuspid Regurgitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36526578" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Invasive Right Ventricular to Pulmonary Artery Coupling in Patients Undergoing Transcatheter Edge-to-Edge Tricuspid Valve Repair.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32176279" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Finding concordance in discord: the value of discordant invasive and echocardiographic pulmonary artery pressure measurements with severe tricuspid regurgitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29332606" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Tricuspid flow and regurgitation in congenital heart disease and pulmonary hypertension: comparison of 4D flow cardiovascular magnetic resonance and echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24224411" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Evaluation of cardiac valvular regurgitant lesions by cardiac MRI sequences: comparison of a four-valve semi-quantitative versus quantitative approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35292799" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
